GLAND / NSE / Biotechnology & Drugs
Gland Pharma
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High2,574
Target Low1,575
Target Mean2.13
Target Median41.67
Risk Metrics
Overall RiskBalanced risk
Board Risk37.44
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Gland Pharma: What Should You Do? BusinessLine
Price to book forward of Gland Pharma Ltd. – NSE:GLAND TradingView
Gland Pharma - Cemindia Projects among 8 small-cap stocks that hit 52-week highs, rally up to 35% in a month The Economic Times
Gland Pharma Ltd gains for third straight session Business Standard
Glandosam from Gland Pharma - heparin prefilled syringes target hospital demand ad-hoc-news.de
Glandes from Gland Pharma - long-selling heparin vials for hospital workloads AD HOC NEWS
Stock FAQs
What is the symbol and ISIN of Gland Pharma?
Gland Pharma has the symbol GLAND and ISIN - INE068V01023.
What is the current price of Gland Pharma?
Gland Pharma is currently trading at INR 2,479.40.
What are the year high and year low of Gland Pharma?
Gland Pharma has a year high of INR 2,574.00 and a year low of INR 1,575.00.
What is the market capitalization of Gland Pharma?
Gland Pharma has a market capitalization of INR 40,877.01 crore.
What is the P/E ratio of Gland Pharma?
Gland Pharma has a P/E ratio of 27.20.
What is the dividend yield of Gland Pharma?
Gland Pharma has a dividend yield of 0.81%.
How is the financial performance of Gland Pharma based on revenue, net income, and EPS?
Gland Pharma has revenue of INR 64,306.50 crore, net income of INR 10,273.16 crore, and EPS of INR 63.40.
What is the book value of Gland Pharma?
Gland Pharma has a book value of INR 604.25.
What is the debt-to-equity ratio of Gland Pharma?
Gland Pharma has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Gland Pharma?
Gland Pharma has a price-to-book ratio of 4.10 and a price-to-sales ratio of 0.64.
© SharekeyX | Rusaka Technologies 2024-2026